SEC Form D · filed June 14, 2018
ADIAL PHARMACEUTICALS, INC
Location
CHARLOTTESVILLE, VA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
James W. Newman, Jr · Charlottesville, VADirectorWilliam B. Stilley, Iii · Charlottesville, VAExec · DirectorJames K. Anderson · Charlottesville, VADirectorRobertson H. Gilliland · Charlottesville, VADirectorTony W. Goodman · Charlottesville, VADirectorJoseph M. Truluck · Charlottesville, VAExecBankole A. Johnson · Charlottesville, VADirectorKevin W. Schuyler, Cfa · Charlottesville, VADirectorRonald Heffernan · Sandy, UTExec · DirectorJesse S. Jacobs · Playa Vista, CADirectorSever Totia · New York, NYDirectorKweli Washington · New York, NYDirectorMike Kerns · Playa Vista, CADirectorW. C. Mccollum · Los Angeles, CAExecJason Bergsman · Playa Vista, CADirectorPeter Feld · New York, NYDirectorUrsula Newman · London, United KingdomDirectorThomas Scriven · Golden, CODirectorMatthew Davis · Purcellville, VADirectorFred Ausubel · Allston, MAExecCory Brown · Nashville, TNDirectorLauren Smith · Nashville, TNDirectorKiran N. Bhatraju · Shepherdstown, WVDirectorMatthew Tomich · New York, NYExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗